Might Estrogen Promote Lung Cancer Progression?
Journal Title: Journal of Clinical and Molecular Endocrinology - Year 2017, Vol 2, Issue 1
Abstract
In order to understand the differences between sexes in lung cancer presentation and due to the observation that young women have worse prognosis, we studied the participation of estrogens in lung carcinogenesis. We found that estradiol increases the expression of CXCR4 and promotes the activation of the CXCL12/CXCR4 axis, an important chemokine pathway involved in lung carcinogenesis and tumor progression.
Authors and Affiliations
Vianey Rodriguez Lara
Keywords
Related Articles
- EP ID EP305648
- DOI 10.21767/2572-5432.100038
- Views 49
- Downloads 0
False Positive TSH Receptor Binding Inhibitory Immunoglobulin in a Patient with Overt Hyperthyroidism Caused by Painless Thyroiditis
The diagnosis of Graves’s disease (GD) can be challenging in patients with atypical presentations of hyperthyroidism. Recently, TSH receptor antibody assays are proposed as first-line test for suspected GD. I here report...
Might Estrogen Promote Lung Cancer Progression?
In order to understand the differences between sexes in lung cancer presentation and due to the observation that young women have worse prognosis, we studied the participation of estrogens in lung carcinogenesis. We foun...
Aromatase Inhibitors Combined with Growth Hormone: A Cost-effective Last Chance for Improving Boysâ Stature at the Near-End of Growth?
Two studies have recently shown a clear benefit of using nonsteroidal aromatase inhibitors (AIs) in combination with growth hormone (rhGH) in pubertal boys of very short stature (between -2.5 and - 3 SDS) who are approac...
Ketotifen and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
Objective: Mast cells found to be an important contributor to inflammation, obesity, diabetes and atherosclerosis. We evaluate the ability of ketotifen to reduce cardiovascular risk in patient with type 2 diabetes millet...
Antidiabetics and Heart Failure - Large Trials but Little Mechanistic Insight
Glucose lowering efficacy was the basis for the approval of antihyperglycaemic drug in the past. However, increasing concerns emerged about potential cardiovascular side effects of these drugs following the metaanalysis...